Journalists Damian Garde and Elaine Chen are leaving STAT to join Bloomberg News, with Garde set to cover large drug companies. Chen will focus on the biotech industry, including obesity, diabetes, and heart drugs, expanding her coverage to all of biopharma.
Great get for Bloomberg -- I'm excited to continue to follow @damiangarde's work. We are so fortunate to have talented journalists like him covering biopharma! https://t.co/ix2XMHdCCG
Onward… @elaineywchen is STAT’s new national biotech reporter. Follow her now, please. This was an easy choice for us because Elaine is an outstanding journalist. In her short time at STAT already, she has commanded our cardiovascular and obesity coverage. Elaine covers…
Follow @elaineywchen as she takes on a broader beat covering the biotech industry after absolutely crushing STAT's coverage of weight-loss drugs! https://t.co/R6laxtdn7t
We've all watched Elaine come in and dominate the cardio-metabolic disease beat. Sad to lose her as my chronic disease sister, but excited to see what she does on the biotech team! https://t.co/kIcZ8b4QDQ
Beyond gutted the brilliant @damiangarde is leaving his post @statnews, but absolutely thrilled that @elaineywchen is taking his place! You know her for her smart coverage of obesity and obesity drugs, but she'll be expanding to all of biopharma. Send her your #biotech tips! https://t.co/NfsxT9kofw
Job update: Starting next week, I’ll be moving onto the biotech team at STAT. As a national biotech reporter, I’ll still be covering obesity, diabetes and heart drugs, but also many other drugs and the biopharma industry as a whole. Send ideas, tips to [email protected]
Hello! Not to spoil the shock but the news is that I'm leaving STAT after eight wonderful years and will soon be covering some very large drug companies with the team Bloomberg News. https://t.co/krBXCO286p